Critical Care

  • Spontaneous coronary artery dissection: Principles of management
    Nicole Pristera, MD, Pulkit Chaudhury, MD, Erik H. Van Iterson, PhD and Leslie S. Cho, MD
    Cleveland Clinic Journal of Medicine November 2021, 88 (11) 623-630; DOI: https://doi.org/10.3949/ccjm.88a.20162

    Once thought to be rare, it is increasingly recognized as a common cause of acute coronary syndrome, particularly in young women.

  • Medical, ethical, and legal aspects of end-of-life dilemmas in the intensive care unit
    Jonathan Wiesen, MD, Christopher Donatelli, MD, Martin L. Smith, STD, Laurel Hyle, JD, MPH and Eduardo Mireles-Cabodevila, MD
    Cleveland Clinic Journal of Medicine September 2021, 88 (9) 516-527; DOI: https://doi.org/10.3949/ccjm.88a.14126

    Three hypothetical cases elucidate medical, ethical, and legal considerations in common end-of-life situations encountered in the ICU.

  • The obesity paradox in heart failure: What is the role of cardiorespiratory fitness?
    Asad Khan, MD, Erik H. Van Iterson, PhD and Luke J. Laffin, MD
    Cleveland Clinic Journal of Medicine August 2021, 88 (8) 449-458; DOI: https://doi.org/10.3949/ccjm.88a.20098

    What should these patients be advised about weight management and about cardiorespiratory fitness, a major factor influencing the paradox?

  • The current state of tobacco cessation treatment
    Humberto K. Choi, MD, FCCP, Jorge Ataucuri-Vargas, MD, Charlie Lin, MD and Amanda Singrey, PharmD, BCACP, CTTS
    Cleveland Clinic Journal of Medicine July 2021, 88 (7) 393-404; DOI: https://doi.org/10.3949/ccjm.88a.20099

    Behavioral interventions and pharmacotherapy increase success rates. Alternative treatments should not replace or delay the use of known effective therapies.

  • Post-acute sequelae of SARS-CoV-2 infection: Caring for the ‘long-haulers’
    Susan Vehar, MD, Marina Boushra, MD, Prince Ntiamoah, MD and Michelle Biehl, MD, MS
    Cleveland Clinic Journal of Medicine May 2021, 88 (5) 267-272; DOI: https://doi.org/10.3949/ccjm.88a.21010

    An estimated 10% of COVID-19 survivors continue to experience symptoms weeks to months after symptoms appear.

  • Is regular oxygen supplementation safe for obese postoperative patients?
    Roop Kaw, MD and Anthony G. Doufas, MD, PhD
    Cleveland Clinic Journal of Medicine December 2020, 87 (12) 723-727; DOI: https://doi.org/10.3949/ccjm.87a.19051

    Caution for some, but no evidence to support withholding it altogether.

  • Neurologic complications of COVID-19
    Catherine E. Hassett, DO, Aron Gedansky, MD, Ibrahim Migdady, MD, Adarsh Bhimraj, MD, Ken Uchino, MD and Sung-Min Cho, DO
    Cleveland Clinic Journal of Medicine December 2020, 87 (12) 729-734; DOI: https://doi.org/10.3949/ccjm.87a.ccc058

    Human coronaviruses, including SARS-CoV-2, can be neurotropic.

  • Recognition and management of respiratory co-infection and secondary bacterial pneumonia in patients with COVID-19
    Chao-Ping Wu, MD, Fatima Adhi, MD and Kristin Highland, MD
    Cleveland Clinic Journal of Medicine November 2020, 87 (11) 659-663; DOI: https://doi.org/10.3949/ccjm.87a.ccc015

    Consider the presentation and trajectory of illness.

  • Convalescent plasma for COVID-19: Promising, not proven
    Simon R. Mucha, MD and NurJehan Quraishy, MD
    Cleveland Clinic Journal of Medicine November 2020, 87 (11) 664-670; DOI: https://doi.org/10.3949/ccjm.87a.ccc056

    The evidence is suggestive but weak. Trials are ongoing.

  • SARS-CoV-2 and myocardial injury: Few answers, many questions
    SARS-CoV-2 and myocardial injury: Few answers, many questions
    Paul C. Cremer, MD
    Cleveland Clinic Journal of Medicine September 2020, 87 (9) 521-525; DOI: https://doi.org/10.3949/ccjm.87a.ccc001

    What is the mechanism? Is this a distinct population? What are the treatment options?

Pages